A

Aileron Therapeutics Inc
NASDAQ:ALRN

Watchlist Manager
Aileron Therapeutics Inc
NASDAQ:ALRN
Watchlist
Price: 2.11 USD 9.33% Market Closed
Market Cap: 45.7m USD

Relative Value

There is not enough data to reliably calculate the relative value of ALRN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALRN Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
24
Forward
-0.9
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
21.6
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
23.7
vs History
68
vs Industry
71
Median 3Y
0.5
Median 5Y
0.6
Industry
3.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
31
Median 3Y
-1
Median 5Y
-1
Industry
6.7
vs History
vs Industry
30
Median 3Y
-1
Median 5Y
-1
Industry
7.2
Forward
-0.7
vs History
vs Industry
31
Median 3Y
-1
Median 5Y
-1
Industry
8.2
vs History
vs Industry
28
Median 3Y
-1
Median 5Y
-1
Industry
6.7
vs History
55
vs Industry
67
Median 3Y
0.3
Median 5Y
0.5
Industry
5.7

Multiples Across Competitors

ALRN Competitors Multiples
Aileron Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Aileron Therapeutics Inc
NASDAQ:ALRN
45.7m USD 0 -1.6 -1 -0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 111 463.2 -162 126.7 -196 873.6 -194 627
US
Abbvie Inc
NYSE:ABBV
397B USD 6.7 169.1 16.4 23.2
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 4.7 24.3 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
149.6B USD 5.1 18.4 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.4B USD 9.5 30.3 22.2 23.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 065.3 -527 -573.9 -558.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.5B USD 5.3 16.5 15.6 17.7
AU
CSL Ltd
ASX:CSL
87.9B AUD 3.8 19.5 13.1 16.3
NL
argenx SE
XBRU:ARGX
47B EUR 15.2 35.7 61.8 63.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
54B USD 16.8 1 239.6 163 197.7
P/S Multiple
Revenue Growth P/S to Growth
US
A
Aileron Therapeutics Inc
NASDAQ:ALRN
Average P/S: 3 411 359.6
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 111 463.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
5%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
10%
0.9
US
E
Epizyme Inc
F:EPE
2 065.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.3
6%
0.9
AU
CSL Ltd
ASX:CSL
3.8
5%
0.8
NL
argenx SE
XBRU:ARGX
15.2
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.8
46%
0.4
P/E Multiple
Earnings Growth PEG
US
A
Aileron Therapeutics Inc
NASDAQ:ALRN
Average P/E: 194.2
Negative Multiple: -1.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 126.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.3
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
9%
1.8
AU
CSL Ltd
ASX:CSL
19.5
11%
1.8
NL
argenx SE
XBRU:ARGX
35.7
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 239.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
A
Aileron Therapeutics Inc
NASDAQ:ALRN
Average EV/EBITDA: 40.3
Negative Multiple: -1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 873.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.6
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
NL
argenx SE
XBRU:ARGX
61.8
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
A
Aileron Therapeutics Inc
NASDAQ:ALRN
Average EV/EBIT: 46.5
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 627 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -558.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
13%
1.4
AU
CSL Ltd
ASX:CSL
16.3
11%
1.5
NL
argenx SE
XBRU:ARGX
63.5
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.7
N/A N/A